A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2-Reference-Cited by-同舟云学术

A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2

Published:2015-10-08 Issue:3 Volume:55 Page:341-348
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Soerensen Anne V.¹,Geertsen Poul F.¹,Christensen Ib J.²,Hermann Gregers G.³,Jensen Niels V.⁴,Fode Kirsten⁵,Petersen Astrid⁶,Sandin Rickard⁷,Donskov Frede⁵

Affiliation:

1. Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark,

2. The Finsen Laboratory, Rigshospitalet and Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark,

3. Department of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark,

4. Department of Oncology, Odense University Hospital, Odense, Denmark,

5. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark,

6. Department of Pathology, Aalborg University Hospital, Aalborg, Denmark, and

7. Pfizer Oncology, Sollentuna, Sweden

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/0284186X.2015.1091499

Reference25 articles.

1. Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2

2. Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

3. Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma

4. Hypothyroidism in patients with renal cell carcinoma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial;BMC Cancer;2024-02-24

2. Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment;Current Vascular Pharmacology;2019-10-02

3. Elevated neutrophil-lymphocyte ratio combined with hyponatremia indicate poor prognosis in renal cell carcinoma;Acta Oncologica;2019-08-26

4. Folic Acid Reduces Mucositis in Metastatic Renal Cell Carcinoma Patients: A Retrospective Study;Clinical Genitourinary Cancer;2019-08

5. Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy;International Journal of Radiation Biology;2018-10-16